SG11201604972TA - Fgf-18 formulation in alginate/collagen hydrogels - Google Patents

Fgf-18 formulation in alginate/collagen hydrogels

Info

Publication number
SG11201604972TA
SG11201604972TA SG11201604972TA SG11201604972TA SG11201604972TA SG 11201604972T A SG11201604972T A SG 11201604972TA SG 11201604972T A SG11201604972T A SG 11201604972TA SG 11201604972T A SG11201604972T A SG 11201604972TA SG 11201604972T A SG11201604972T A SG 11201604972TA
Authority
SG
Singapore
Prior art keywords
fgf
alginate
formulation
collagen hydrogels
hydrogels
Prior art date
Application number
SG11201604972TA
Other languages
English (en)
Inventor
Fabiana Canal
Presti Caterina Lo
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of SG11201604972TA publication Critical patent/SG11201604972TA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/26Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/505Stabilizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • A61L2300/414Growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/06Flowable or injectable implant compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/06Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polymers & Plastics (AREA)
  • Materials For Medical Uses (AREA)
SG11201604972TA 2013-12-24 2014-12-23 Fgf-18 formulation in alginate/collagen hydrogels SG11201604972TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13199591 2013-12-24
PCT/EP2014/079205 WO2015097236A2 (fr) 2013-12-24 2014-12-23 Formulation de fgf -18 dans des hydrogels à base d'alginate/collagène

Publications (1)

Publication Number Publication Date
SG11201604972TA true SG11201604972TA (en) 2016-07-28

Family

ID=49882942

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201604972TA SG11201604972TA (en) 2013-12-24 2014-12-23 Fgf-18 formulation in alginate/collagen hydrogels

Country Status (17)

Country Link
US (1) US9795714B2 (fr)
EP (1) EP3086822B1 (fr)
JP (1) JP6487448B2 (fr)
KR (1) KR102434024B1 (fr)
CN (1) CN106068131B (fr)
AU (1) AU2014372578B2 (fr)
BR (1) BR112016014717B1 (fr)
CA (1) CA2934638C (fr)
ES (1) ES2806026T3 (fr)
HK (1) HK1225657A1 (fr)
IL (1) IL246407B (fr)
MX (1) MX368970B (fr)
NZ (1) NZ721597A (fr)
RU (1) RU2698210C2 (fr)
SG (1) SG11201604972TA (fr)
WO (1) WO2015097236A2 (fr)
ZA (1) ZA201604610B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2658909C2 (ru) 2013-02-14 2018-06-26 НАНОПАРЕЙЛ, ЭлЭлСи Гибридные войлоки из нановолокон, полученных электропрядением
ES2865723T3 (es) 2013-12-24 2021-10-15 Ares Trading Sa Formulación de FGF-18 en geles de xiloglucano
PT3107592T (pt) * 2014-02-20 2018-12-03 Merck Patent Gmbh Implante que compreende fgf-18
US10408686B2 (en) * 2016-01-15 2019-09-10 Temptime Corporation Gel-based temperature indicators
EP3821920A4 (fr) * 2018-07-13 2022-03-02 T-ACE Medical Co., Ltd. Combinaison pour chirurgie endoscopique
JP7388722B2 (ja) * 2018-08-10 2023-11-29 国立大学法人 東京大学 アルギン酸中空マイクロファイバ
US20210369875A1 (en) * 2018-11-06 2021-12-02 National Cancer Center Alginic acid-based injectable hydrogel system
CN111068116B (zh) * 2019-12-28 2022-03-22 河北柯瑞生物医药有限公司 一种注射用软骨修复温敏凝胶及其制备方法
US20230256138A1 (en) * 2020-05-14 2023-08-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Composite product for the osteoarticular regeneration of cartilage lesion
CN112263505A (zh) * 2020-10-29 2021-01-26 广州栋方生物科技股份有限公司 一种铜肽组合物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2254350A1 (fr) * 1998-11-17 2000-05-17 Hsc Research And Development Limited Partnership Methode d'obtention de cartilage par genie biologique
US6451346B1 (en) * 1998-12-23 2002-09-17 Amgen Inc Biodegradable pH/thermosensitive hydrogels for sustained delivery of biologically active agents
US6355204B1 (en) * 2000-06-07 2002-03-12 Owens-Brockway Plastic Products Inc. Method of manufacturing a dual-chamber container
WO2004000347A1 (fr) * 2002-06-21 2003-12-31 Novo Nordisk A/S Compositions solides stabilisees de polypeptides de facteur vii
AU2003279835B2 (en) 2002-10-07 2009-09-10 Zymogenetics, Inc. Methods of administering FGF18
EP1799232B1 (fr) 2004-10-12 2015-10-07 FMC Biopolymer AS Systemes d'alginate auto-gelifiants et utilisations associees
US8741326B2 (en) * 2006-11-17 2014-06-03 Abbott Cardiovascular Systems Inc. Modified two-component gelation systems, methods of use and methods of manufacture
WO2009127940A1 (fr) * 2008-04-14 2009-10-22 Adocia Composition osteogenique comprenant un complexe facteur de croissance/polymere amphiphile un sel soluble de cation e un support organique
JP2011160817A (ja) * 2010-02-04 2011-08-25 Univ Of Tokyo 移植支援材料
CN103221066A (zh) * 2010-10-15 2013-07-24 国立大学法人京都大学 缓释性药物组合物
US10034737B2 (en) * 2011-02-22 2018-07-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nano-reservoirs technology for use in bone and/or cartilage regeneration
TWI527590B (zh) 2011-06-17 2016-04-01 艾瑞斯貿易公司 Fgf-18之凍乾調配物
ES2865723T3 (es) 2013-12-24 2021-10-15 Ares Trading Sa Formulación de FGF-18 en geles de xiloglucano

Also Published As

Publication number Publication date
MX2016008442A (es) 2017-01-11
AU2014372578B2 (en) 2018-03-01
US20160303291A1 (en) 2016-10-20
EP3086822A2 (fr) 2016-11-02
CA2934638A1 (fr) 2015-07-02
ZA201604610B (en) 2018-11-28
RU2016129817A3 (fr) 2018-08-24
WO2015097236A2 (fr) 2015-07-02
BR112016014717A2 (pt) 2017-09-19
US9795714B2 (en) 2017-10-24
KR20160101163A (ko) 2016-08-24
HK1225657A1 (zh) 2017-09-15
AU2014372578A1 (en) 2016-07-14
CN106068131A (zh) 2016-11-02
RU2698210C2 (ru) 2019-08-23
MX368970B (es) 2019-10-23
EP3086822B1 (fr) 2020-04-15
KR102434024B1 (ko) 2022-08-22
IL246407A0 (en) 2016-08-31
RU2016129817A (ru) 2018-01-30
JP2017502042A (ja) 2017-01-19
BR112016014717B1 (pt) 2020-12-01
WO2015097236A3 (fr) 2015-09-17
NZ721597A (en) 2022-07-01
CA2934638C (fr) 2022-07-12
JP6487448B2 (ja) 2019-03-20
ES2806026T3 (es) 2021-02-16
CN106068131B (zh) 2020-01-17
AU2014372578A2 (en) 2016-11-17
IL246407B (en) 2020-01-30

Similar Documents

Publication Publication Date Title
HK1225657A1 (zh) 藻酸鹽/膠原水凝膠中的fgf-18製劑
HK1203317A1 (en) Edible composition, preparation method and use thereof
EP2804577A4 (fr) Composition pour coloration sous forme de gel
EP3044695A4 (fr) Partage d'artefacts dans des archives protégées par autorisations
EP3070128A4 (fr) Composition formant hydrogel et hydrogel fabriqué à partir de celle-ci
PL2983641T3 (pl) Hydrożel na bazie polimeru
EP2972349A4 (fr) Compositions de points polymères et procédés associés
PL2916855T3 (pl) Hydrolizat kolagenu i jego zastosowanie
EP2997270A4 (fr) Améliorations de mousquetons
HK1203398A1 (en) Edible composition, preparation method and use thereof
EP3017642A4 (fr) Exécution de mesures dans un réseau sans fil
EP3054919A4 (fr) Formulation de gel de signalisation de redox
IL245140A0 (en) Compositions and methods relating to a barrier polymer hydrogel
HK1203397A1 (zh) 可食用組合物及其製備方法和用途
HK1221639A1 (zh) 交聯的殼聚糖-丙交酯水凝膠
EP3060061A4 (fr) Utilisation de probiotiques dans la viande
EP2938348A4 (fr) Compositions d'alginate et leurs utilisations
EP3057439A4 (fr) Compositions alimentaires contenant des protéines et procédés pour leur préparation et leur utilisation
IL234240B (en) Coagulant formulation based on calcium gluconate
HK1221417A1 (zh) 修飾的水凝膠
EP2967087A4 (fr) Procédé pour réduire la moisissure dans des produits alimentaires cuits à activité de l'eau inférieure
IL246435A0 (en) Gel containing fgf-18
EP3000867A4 (fr) Composition lipidique
ZA201600037B (en) Organometallic 2-cyano-2-aminobenzoate-propyl derivates and their use as anthelmintics
GB2519072B (en) Composition comprising collagen and honey